Sequana Medical is a medical technology company that develops treatments for fluid overload associated with liver disease, heart failure, and cancer. Its primary product is the alfapump system, an implantable medical device designed to automatically remove fluid from the abdominal cavity for patients with recurrent or refractory ascites due to liver cirrhosis.
Subscribe to see SEQUANA MEDICAL’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
SEQUANA MEDICAL is a medical devices company headquartered in Belgium. Xcout tracks 8 named people at SEQUANA MEDICAL, including Ian Crosbie (Chief Executive Officer, CEO).
2 more named people on record for SEQUANA MEDICAL, with roles, board committees and tenure — see the full roster →
A few of SEQUANA MEDICAL's closest competitors — see the full list of competitors and alternatives →
Lymphatica Medtech SA is a medical device company founded in 2017 and based in the EPFL Innovation Park Campus in Ecublens, Switzerland. The company is dedicated to developing solutions to significantly improve the well-being of patients suffering from lymphatic diseases.
Quanta Dialysis Technologies is a medical-device company that develops hemodialysis systems, notably its compact SC+ platform. Its products are intended for use by dialysis providers and healthcare professionals in clinical and home-care settings to treat patients with kidney failure.
BrioHealth Solutions develops medical technology for the treatment of advanced heart failure. The company's primary product is the BrioVAD system, an investigational Left Ventricular Assist System (LVAS) designed to improve the quality of life for heart failure patients.
V-Wave is a medical technology company established in Israel in 2009 that develops percutaneous implantable shunts and technologies for patients with chronic heart failure.
WhiteSwell is a clinical-stage medical technology company headquartered in Galway, Ireland. The company pioneers device-based treatments for acute decompensated heart failure by targeting and supporting the human lymphatic system.
OrganOx is an organ technology company founded as a spin-out from the University of Oxford, United Kingdom. It pioneers liver perfusion technology to address transplant challenges and improve transplant success through innovation and clinical research.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.